Published date: 4 November 2022
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Antivirals for systemic use - 33651400
Location of contract
SW1P 3JR
Value of contract
£1
Procurement reference
CF-1166800D0O000000rwimUAA
Published date
4 November 2022
Closing date
27 July 2022
Closing time
12pm
Contract start date
28 July 2022
Contract end date
27 July 2023
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.
Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate the price per dose. Publication of this information would therefore: (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vendors; and (iii) impact fair competition between vendors.
More information
Previous notice about this procurement
TPOXX® Antiviral Treatment (Tecovirimat)
- Awarded contract
- Published 4 November 2022
Attachments
-
- MMT - UKDHSC TPOXX Conditions of Contract 27072022 _Redacted 03112022.pdf
- MMT - UKDHSC TPOXX Conditions of Contract 27072022 _Redacted 03112022
Award information
Awarded date
28 July 2022
Contract start date
28 July 2022
Contract end date
27 July 2023
Total value of contract
£1
This contract was awarded to 1 supplier.
MERIDIAN MEDICAL TECHNOLOGIES LIMITED
Address
Forsyth House, Cromac Square, Belfast, Co. Antrim, BT2 8LA BT2 8LA
Reference
None
Supplier is SME?
Yes
About the buyer
Contact name
Simeon Hadebe
Address
Nobel House, 17 Smith Square
London
SW1P 3JR
GB
Share this notice
Closing: 27 July 2022, 12pm